FDA Investigator: Amanda L. Fyles

- Amanda L. Fyles first started conducting FDA inspections in 2016, with the last inspection in 2019. Over that time, Amanda L. Fyles has conducted 12 inspections at 12 companies across 12 sites.

Get Amanda Fyles's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 IDT Australia Ltd., Boronia | 2019

Out-of-stock
Amanda L. Fyles
Animal Drugs & Feed Form 483

FDA 483 Teva Parenteral Manufacturing, Irvine | 2019

Out-of-stock
Amanda L. Fyles
Human Drug Form 483

FDA 483 University of Southern CA, DBA USC Molecular Imaging Center, Los Angeles | 2018

Out-of-stock
Amanda L. Fyles
Human Drug Form 483

FDA 483 Bend Research, Inc., Bend | 2018

Out-of-stock
Amanda L. Fyles
Human Drug Form 483

FDA 483 B. Braun Medical Inc., Irvine | 2018

Out-of-stock
Amanda L. Fyles
Human Drug Form 483

FDA 483 Shadow Holdings DBA Bocchi Labs, Santa Clarita | 2018

Out-of-stock
Amanda L. Fyles
Human Drug Form 483

FDA 483 INSYS DEVELOPMENT COMPANY, INC., Chandler | 2018

Out-of-stock
Amanda L. Fyles
Human Drug Form 483

FDA 483 Amphastar Pharmaceuticals, Inc., Rancho Cucamonga | 2017

Out-of-stock
Amanda L. Fyles
Human Drug Form 483

FDA 483 Exova Inc., Santa Fe Springs | 2016

Out-of-stock
Amanda L. Fyles
Animal Drugs & Feed Form 483